Trial Profile
EUropean REgistry in Children below six years of age treated with BeneFIX
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2021
Price :
$35
*
At a glance
- Drugs Nonacog alfa (Primary)
- Indications Haemophilia B
- Focus Adverse reactions
- Acronyms EUREKIX
- Sponsors Pfizer
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 17 Oct 2015 New trial record